Autoimmune Mechanisms in Focal Epilepsy of Unknown Cause

Abstract

The manifestation of immunological findings in diverse disorders presenting with seizures points to autoimmunity and inflammation in the etiology of epilepsy. Typical examples of autoimmunity‑associated epilepsy are autoimmune encephalitis, Rasmussen encephalitis, and glutamic acid decarboxylase (GAD) antibody‑positive temporal lobe epilepsy (TLE). The last entity is a typical example of antibody‑positive focal epilepsy of unknown cause (FEUC). One of the most prominent findings emphasizing the coexistence of epilepsy and autoimmunity is the detection of anti‑neuronal antibodies in patients manifesting with seizures. Emergence of antibody‑producing plasma cells in the early course of GAD‑antibody‑positive TLE and induction of seizures in rodents upon intracerebral administration of N‑methyl‑D‑aspartate receptor antibodies indicate that anti‑neuronal antibodies may play a causal (rather than bystander) role in the induction of seizures. By contrast, innate immunity of the central nervous system (CNS) and infiltrating cytotoxic T‑cells appear to participate in Rasmussen encephalitis and autoimmune encephalitis with antibodies to intracellular antigens. In addition, repetitive seizures may activate glial cells through the release of damage‑associate molecular pattern mediators and activation of toll‑like receptors, which in turn leads to disrupted blood–brain barrier and increased cerebral infiltration of peripheral blood immune cells. In conclusion, complex interactions of humoral and cellular immunity in the CNS appear to cause or at least contribute to seizure induction in FEUC. The nature of these interactions has recently started to be understood. Investigation of these mechanisms is substantial for the discovery of new treatment strategies and biomarkers in epilepsy.